Mindset Pharma Inc.
MSSTF · OTC
6/30/2022 | 6/30/2021 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $4 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $4 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| R&D Expenses | $7 | $2 | $0 | $0 |
| G&A Expenses | $13 | $6 | $0 | $0 |
| SG&A Expenses | $13 | $6 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | $0 | $0 |
| Operating Expenses | $20 | $8 | $0 | $0 |
| Operating Income | -$17 | -$5 | -$0 | -$0 |
| % Margin | -424.4% | – | – | – |
| Other Income/Exp. Net | -$0 | -$6 | $0 | $0 |
| Pre-Tax Income | -$17 | -$12 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$17 | -$12 | -$0 | -$0 |
| % Margin | -425.2% | – | – | – |
| EPS | -0.18 | -0.2 | -0.001 | -0 |
| % Growth | 10% | -39,900% | -150% | – |
| EPS Diluted | -0.18 | -0.2 | -0.001 | -0 |
| Weighted Avg Shares Out | 90 | 58 | 66 | 66 |
| Weighted Avg Shares Out Dil | 90 | 58 | 66 | 66 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$17 | -$5 | -$0 | -$0 |
| % Margin | -423.2% | – | – | – |